LYEL filings
Corporate insider profile
Lynn Seely Filing Activity
Latest reported as President and CEO of Lyell Immunopharma, Inc. (LYEL).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$7,337.08
- Latest transaction
- May 11, 2026
Affiliated corporations
Reported company relationships
Transaction history
